Search
for
Sort by
Research 121–150 of 1000+
- Chapter 17. Selective androgen receptor modulators (SARMs)
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Cutaneous drug reactions
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Psychoactive drugs and skin
- Dermatologic manifestations of endocrine disorders
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Thymosin β4 Promotes Dermal Healing
- Utilizing Electromagnetic Radiation for Hair Growth
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Adverse cutaneous effects of psychotropic medications
- Impact of Chemotherapeutic Drug on People living with Cancer
- A Murine Model for Inducing and Manipulating Hair Follicle Regression (Catagen): Effects of Dexamethasone and Cyclosporin A
- Subject Index
- A mini review on phytochemical and therapeutic potentiality of Hibiscus: An ornamental plant species
- Advances in Hair Diseases
- Cutaneous Reactions to Drugs
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- A Case of Cicatricial Alopecia Associated with Erlotinib
- HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia
- Vitamin D and the skin: Focus on a complex relationship: A review
- Causes of hair loss and the developments in hair rejuvenation
- The control of hair growth: An overview
- Hypersensitivity Reactions to Anticoagulant Drugs
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- What Ages Hair?
- Integral Roles of Specific Proteoglycans in Hair Growth and Hair Loss: Mechanisms behind the Bioactivity of Proteoglycan Replacement Therapy with Nourkrin® with Marilex® in Pattern Hair Loss and Telogen Effluvium
- Malignant epithelial tumors: Part II. Therapy and prevention
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology